Inventory, Net of Intra-Cellular Therapies, Inc. from 31 Mar 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Intra-Cellular Therapies, Inc. quarterly Inventory, Net in USD history and change rate from 31 Mar 2020 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Inventory, Net for the quarter ending 31 Dec 2024 was $26,283,000, a 126% increase year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $26,283,000 +$14,636,000 +126% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $23,539,000 -$19,447,000 -45% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $20,082,000 -$21,813,000 -52% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $15,949,000 -$12,392,000 -44% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $11,647,000 -$12,273,000 -51% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $42,986,000 +$19,389,000 +82% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $41,895,000 +$16,873,000 +67% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $28,341,000 +$20,448,000 +259% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $23,920,000 +$15,972,000 +201% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $23,597,000 +$15,430,065 +189% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $25,022,000 +$17,253,152 +222% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $7,893,000 +$313,607 +4.1% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $7,948,000 +$891,615 +13% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $8,166,935 +$5,219,797 +177% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $7,768,848 +$5,433,806 +233% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $7,579,393 +$6,188,269 +445% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $7,056,385 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $2,947,138 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $2,335,042 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $1,391,124 31 Mar 2020 10-Q 07 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.